Terms of Use

Use of this Site

This site is controlled and operated by Laboratoire HRA Pharma (hereafter “HRA Pharma”), ID number 420 792 582 RCS Nanterre located 200 avenue de Paris, F-92 320 Châtillon, France, and its subsidiaries (phone: + 33 (0) 1 40 33 11 30). Access to and use of this site are subject to these Terms of Use and to all applicable laws and regulations. By accessing and using this site, you accept, without limitation or qualification, these Terms of Use.

HRA Pharma reserves the right to change these Terms of Use from time to time without notice, as it deems necessary; you are therefore advised to check them regularly.

This site is publicly available.

This site is not intended to be used as a source of medical advice or opinion. Under no circumstances should anything provided on this site be used to establish a medical diagnosis, which can only be achieved by consulting a qualified doctor.

Content and Liability

This site has been created to provide general information on emergency contraception. It has been developed in accordance with the principles of international regulations.

You agree that access to and use of this site and the content thereof is at your own risk. HRA Pharma and any party involved in creating, producing or delivering this site hereby expressly exclude:

-All conditions, warranties and other terms that might otherwise be implied by statute, common law or the law of equity,

-Any liability for any direct, indirect or consequential loss or damage incurred by any user arising out of access to, use of or inability to use this site, or any errors or omissions in the content thereof.

HRA Pharma accepts no liability for any loss or damage caused by a distributed denial of service attack, viruses or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of the audio, video, data or text on the site or any other aspect of the site.

Registration and Privacy

HRA Pharma respects the privacy of its registered site users, and users should refer to the  Privacy Policy for disclosures related to the collection and use of your personal information.

Trademarks and Logos

You may not use in any way of the trademarks and logos used within this site.

Copyright

HRA Pharma is the owner or licensee of all copyright in the site. All such rights are reserved. You may download and retain on your disk or in hard-copy form a single copy of material published on this site only for your personal, non-commercial use, provided that you do not remove any copyright or other proprietary notices. You may not otherwise copy, distribute, display, download, modify, repost, transmit or use all or part of any material without HRA Pharma’s prior written permission. You may not mirror on another web server all or part of any material published by HRA Pharma on this site, and you may not copy any of the graphics contained in any material published on this site.

Nothing contained herein shall be construed as conferring by implication, estoppels or otherwise any license or right under any patent or trademark of HRA Pharma, or any third party. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right to any copyright work of which HRA Pharma is the owner or licensee.

Reservation of Rights

HRA Pharma reserves the right to alter or delete material from this site at any time without notice.

General Compliance with Laws

You agree that you will only use the Site for lawful purposes.
You must comply with all laws, statutes, ordinances and regulations which apply to you in relation to your use of the Site.

Miscellaneous

If any provision of these Terms of Use is held to be unlawful, void or unenforceable, then such provision shall be severable without affecting the validity, legality or enforceability of all remaining provisions. Except as expressly provided, these Terms of Use constitute the entire agreement between you and HRA Pharma with respect to the use of this site and content.

 

Last update: April 2019